This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: GORTEC 2017-01 REACH Trial - Avelumab-Cetuximab-RT vs. Standards of Care in Patients With Locally Advanced SCC of Head & Neck

58 views
September 23, 2024
Comments 0
Login to view comments. Click here to Login